Login / Signup
Predisposition to conjunctivitis and male sex reduces drug survival of dupilumab in adults and adolescents.
Luca Mastorino
Irene Richiardi
Federica Gelato
Giovanni Cavaliere
Pietro Quaglino
Michela Ortoncelli
Simone Ribero
Published in:
Expert opinion on biological therapy (2024)
Male gender and predisposition to allergic conjunctivitis are negative predictors for maintenance of response to treatment with dupilumab and consequently associated with lower DS rates.
Keyphrases
</>
atopic dermatitis
young adults
physical activity
mental health
emergency department
combination therapy
free survival
adverse drug
drug induced
electronic health record